Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

OTHER 2 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

pembrolizumab 170 Carboplatin 131 Cisplatin 80 Paclitaxel 77 Gemcitabine 74 Pemetrexed 73 Bevacizumab 62 Docetaxel 56 Fluorouracil 50 Oxaliplatin 48 Dexamethasone 44 durvalumab 40 Leucovorin 39 Capecitabine 38 atezolizumab 37 130-nm albumin-bound paclitaxel 35 Rituximab 34 Cetuximab 34 Nivolumab 33 Fulvestrant 33 Cyclophosphamide 32 Injections 31 Prednisone 29 Lenalidomide 29 enzalutamide 28 venetoclax 25 Letrozole 25 Irinotecan 25 pomalidomide 23 daratumumab 20

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Bupropion × 30 days × Clear all

NCT05646862 2026-05-06

INAVO121

Hoffmann-La Roche

Phase 3 Active not recruiting

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡